Alternatives to EyeGate Pharmaceuticals
EyeGate Pharmaceuticals is a Biotech tool: clinical-stage specialty pharmaceutical company developing therapeutics and drug delivery systems for ophthalmic diseases. Here are the 60 closest alternatives, compared on pricing, features and what real users say.
The 20 closest Biotech companies to EyeGate Pharmaceuticals
- Website
Retispec58HealthTechOulu, Finland$11.1MAI-powered eye exam for early detection of neurodegenerative diseases like Alzheimer's.
- Website
Ray Therapeutics53BiotechnologyBerkeley, USA$243.0MPioneering vision restoration therapies for severe retinal degenerations.
- Website
BeiGene64BiotechCambridge, United States$358.0MA global oncology company developing and commercializing innovative cancer treatments.
- Website
Sylentis55BiotechMadrid, Spain$135.0MOphthalmic pharmaceutical company developing novel treatments for ocular diseases.
- Website
Alector55BiotechSouth San Francisco, United States$162.5MBiotechnology company developing immuno-neurology therapies for neurodegenerative diseases.
- Website
PhosPrint53BiotechAthens, Greece$1.0MBiotech startup developing laser bioprinting systems for regenerative medicine and biosensor applications.
- Website
ANI Pharmaceuticals49BiotechBaudette, United States$670.5MDiversified biopharmaceutical company focused on rare diseases, generics, and established brands.
- Website
Braeburn44BiotechPlymouth Meeting, United States$133.0MDevelops long-acting implantable and injectable therapies for opioid addiction and chronic pain.
- Website
NRG Therapeutics42BiotechStevenage, United Kingdom$58.6MA biotechnology company developing small molecule drugs to treat neurodegenerative diseases by targeting mitochondrial dysfunction.
- Website
Editas Medicine42BiotechCambridge, United States$210.0MA clinical-stage biotechnology company developing transformative genome editing medicines for serious diseases.
- Website
Mironid59BiotechnologyGlasgow, United Kingdom$46.0MBiopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).
- Website Maasbiolabs37Biotech$1.0M
AI-powered platform accelerating biological research and drug discovery.
- Website
Belkin Vision56HealthcareGeneva, Switzerland$38.5MAlcon is a global leader in eye care, providing a broad portfolio of products to enhance sight and improve lives.
- Website
Verdiva Bio54BiotechnologySan Diego, United States$170.0MClinical-stage biopharmaceutical company developing next-generation therapies for obesity and cardiometabolic diseases.
- Website
Amgen34BiotechThousand Oaks, United States$40.0MA global biotechnology company discovering, developing, manufacturing, and delivering innovative human therapeutics.
- Website
Denali Therapeutics70BiotechSouth San Francisco, United States$1.0BBiopharmaceutical company developing therapies for neurodegenerative diseases, focusing on crossing the blood-brain barrier.
- Website
Cradle69BiotechAmsterdam, Netherlands$102.4MCradle Bio B.V. is a Dutch, Swiss biotechnology company that develops software using machine learning for protein engineering. It was founded in 2021 and is base
- Website
Adaptive Biotechnologies69BiotechSeattle, United States$300.0MLeveraging the adaptive immune system to diagnose and treat disease.
- Website COContraline48BiotechnologyCharlottesville, USA$102.5M
Developing novel male contraceptives.
- Website
BenchSci64BiotechToronto, Canada$197.3MAI-powered platform for understanding disease biology and accelerating drug discovery.
Showing the 20 closest matches. See the rest on the EyeGate Pharmaceuticals profile.
Compare EyeGate Pharmaceuticals head to head
Side by side on what each one does, what it costs, and what real users report.